Location History:
- New York, NY (US) (1985 - 1989)
- Cold Springs, NY (US) (1994)
- Cold Spring, NY (US) (1999 - 2010)
Company Filing History:
9 out of 2,489 
1 out of 269 
Years Active: 1985-2010
Title: The Innovations of Robert E. Canfield: A Pioneering Mind in Cancer Research
Introduction
Robert E. Canfield is a prominent inventor based in New York, NY, recognized for his significant contributions to the field of cancer research. With a remarkable portfolio boasting nine patents, Canfield's work primarily focuses on developing methods for detecting and diagnosing cancer, specifically through the use of tumor-associated markers.
Latest Patents
Among his latest patents is a groundbreaking invention related to tumor-associated markers. This invention outlines various methods that include the creation of monoclonal antibody-producing hybridomas designated 27.F7 and 27.B1. Through these advancements, Canfield has developed innovative techniques for detecting TIP-2 antigen-bearing cancer cells in samples. His methods facilitate the diagnosis of cancer in subjects, enabling the identification of cancer cell presence through immunohistochemical screening of tissue sections. Furthermore, he has devised methods for delivering exogenous material to TIP-2 antigen-bearing cancer cells and monitoring cancer progression, contributing profoundly to cancer treatment methodologies. Notably, the invention includes specific isolated peptides with defined amino acid sequences, expanding the potential applications in cancer diagnostics and therapies.
Career Highlights
Canfield's career is marked by his association with respected institutions, such as Columbia University and the University of Medicine and Dentistry of New Jersey. His innovative approach to research has earned him recognition in the scientific community, where he has made strides in the understanding of cancer markers and therapies.
Collaborations
Throughout his career, Canfield has collaborated with esteemed colleagues, including Steven Birken and Paul H. Ehrlich. These collaborations have enhanced his research output and facilitated the exchange of innovative ideas, further pushing the boundaries of cancer research.
Conclusion
In conclusion, Robert E. Canfield's innovations have made a significant impact on cancer detection and treatment. His extensive work on tumor-associated markers and the development of novel diagnostic techniques showcases his dedication to advancing medical science. As he continues to explore new frontiers in cancer research, Canfield remains a vital figure in the fight against this pervasive disease.